Peter Hébert

Peter Hébert is Co-Founder and Managing Partner of Lux Capital — co-founded the firm in 2000 during the dot-com crash and spun out Lux Research as a separate advisory firm, serving as its founding CEO until 2008.

Peter Hébert co-founded Lux Capital in 2000 at one of the worst moments to start a venture firm — the dot-com crash — betting that deep science and physical technology were being systematically undervalued by a software-obsessed market. He came from Lehman Brothers, where he worked as an equity research analyst, and before that graduated cum laude from Syracuse University's Newhouse School in 1999 as a Chancellor's Scholar — a communications degree, not engineering, which makes his pivot to deep-science investing a deliberate intellectual bet rather than a natural extension. While building Lux Capital he spun out Lux Research in 2003, a technology research and advisory firm, and served as its founding CEO until 2008 — running two organizations simultaneously for part of that stretch. He's also co-founded Young Wall Street, a charitable organization supporting youth causes in New York City, and while still an undergrad at Syracuse in 1998 started Future Business Leaders and Entrepreneurs, a student venture organization. He and his wife Gabriela funded the StartNow series at Syracuse's Center for Digital Media Entrepreneurship. The through-line is institution-building from scratch — firm, spinout, research shop, philanthropic org — at each step in domains where the consensus was skeptical. He writes occasionally on Medium via Lux's publication on conviction and deep-science investing, lectures at Columbia, Cornell, MIT, Stanford, and Yale, and appears on CNBC and Bloomberg TV.

Lux Capital's most recent major move is the January 2026 close of Fund IX at $1.5 billion — the firm's largest fund ever — bringing total assets under management to $7 billion. The fund was oversubscribed, signaling strong LP confidence after a period when many deep-tech funds struggled to raise. In early 2026, Lux also led a $350 million round for Erebor and participated in a $400 million Series B for Cognition at a $10.2 billion valuation in September 2025. The firm added retired four-star General Tony Thomas and former diplomat Brett McGurk as venture partners, and Zach Iscol joined in 2026 — a deliberate build-out of defense and national-security credibility. Earlier in 2025 the firm launched the Lux Helpline to support academic researchers losing federal funding, and formalized its company-creation practice as Lux Labs, having built more than 20 companies since founding.

Lux Capital operates in deep-tech and frontier-science venture, competing most directly with Founders Fund, In-Q-Tel, and Khosla Ventures for early-stage deals in defense, biotech, robotics, and AI infrastructure. The firm's own thesis frames the next decade as a shift from software to capital-intensive, physically constrained businesses — permitting, infrastructure, material science — at exactly the moment when public-sector R&D cuts are creating a private investment premium in biotech and defense. Venture investment in aerospace and defense reached $21.4 billion in 2025 across over 300 deals, a tailwind Lux is positioned to capture through portfolio companies like Anduril Industries, which it backed from seed.

Peter's closest working relationships are his co-founders: Josh Wolfe, who runs the firm's public intellectual presence and thought-leadership, and Robert Paull, who was there at the founding. He also maintains relationships across the broader VC ecosystem — Jake Saper at Emergence Capital and Chad Byers and Pratyush Buddiga at Susa Ventures appear in his network.

  • Co-founded Lux Capital in 2000 and has run it for 25+ years through multiple market cycles → thinks in decades, not fund cycles; unlikely to be rattled by short-term volatility.
  • Spun out Lux Research in 2003 and ran it as founding CEO while co-managing the fund → comfortable holding operational and strategic roles simultaneously; high tolerance for complexity.
  • Communications degree from Newhouse, then equity research at Lehman, then deep-science VC → pattern of moving into domains where his background gives him no obvious edge, suggesting he's drawn to contrarian positioning over credential-matching.
  • Lectures at Columbia, Cornell, MIT, Stanford, Yale, and NSF, and appears on CNBC and Bloomberg TV → comfortable in public intellectual forums; likely engages with ideas at a systems level, not just deal-by-deal.
  • Funded StartNow at Syracuse and co-founded Young Wall Street → philanthropic investment tracked to institution-building, not just writing checks; values creating durable structures.
  • Occasional LinkedIn poster, writes on Medium about conviction and deep-science investing → not a high-volume content producer; when he does write, it tends to be considered and thesis-driven.

Conversation tips

  • He has a specific macro thesis — the shift from software to capital-intensive, physically constrained businesses — ask him where he thinks that thesis is most underpriced right now.
  • His background is communications, not engineering. Don't assume he wants to go deep on technical specs; he'll likely engage more on the market structure, the founding story, and the bet.
  • Reference the Lux Helpline or Lux Labs specifically — both reflect deliberate institution-building beyond fund management, which is clearly a point of pride.
  • He's been at this since 2000 — he has lived through the dot-com crash, 2008, 2022 down-round cycles. Framing anything as 'unprecedented' will land flat; ask instead how the current moment compares to prior inflection points he's navigated.
  • Ask about Fund IX being oversubscribed — it's a recent milestone and a signal about LP conviction in deep tech at a moment when many firms struggled to raise.
  • Open on the Fund IX close — $1.5 billion, oversubscribed in January 2026, the firm's largest ever — and ask what the LP appetite tells him about where institutional money is moving in deep tech.
  • Reference the Lux Helpline, launched in May 2025 to support academic researchers losing federal funding — it's a concrete bet that public R&D cuts create a private-sector opportunity, and it shows a side of Lux that isn't purely return-driven.
  • Mention Lux Labs, formalized in 2024 as the firm's company-creation arm — Lux has built more than 20 companies from scratch since founding, including Kurion (nuclear waste) and Variant Bio (rare genetics), and asking how that internal studio model works is a differentiated entry point most visitors skip.
  1. You co-founded Lux during the dot-com crash when deep science was deeply unfashionable — now defense and biotech are the hottest areas in venture. Does the thesis feel more crowded, or do you think the mainstream still underestimates what it takes to build in physical science?
  2. Lux Labs formalizes something you've been doing informally for two decades — building companies from ideas rather than just backing founders. What does the pipeline look like, and how do you decide when to incubate versus invest?
  3. You brought in a retired four-star general and a former diplomat as venture partners in the last year — how much does government and defense credibility actually move the needle for your portfolio companies in classified or regulated sectors?

Don't treat software and AI as the main story — his public thesis is explicitly that the next decade belongs to capital-intensive, physically constrained businesses, and leading with pure-software or SaaS framing signals you haven't read the room.

Make it yours

Tailor these openers to what you sell

These openers are generic. Sign in and tell Brief what you sell — it rewrites the hooks and questions around your pitch.

Brief on your next meeting?

Type any name. Get a structured pre-meeting brief in seconds.

Try Brief →

Generated by briefthecall.com from public web sources on July 5, 2026. Each claim is linked to its source above.

Automatically generated by AI from public sources. May be inaccurate or out of date. Remove or correct this profile →